Column Capital Advisors, LLC Eli Lilly & CO Transaction History

Column Capital Advisors, LLC

$1.92 Billion
Q3 2023

A detailed history of Column Capital Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Column Capital Advisors, LLC holds 783,826 shares of LLY stock, worth $717 Million. This represents 21.95% of its overall portfolio holdings.

Number of Shares

783,826

Previous 787,836 0.51%

Holding current value

$717 Million

Previous $369 Million 13.95%

% of portfolio

21.95%

Previous 18.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$434.7 - $599.3 $1.74 Million - $2.4 Million	-4,010 Reduced 0.51%	783,826 $421 Million
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $218,160 - $291,705	622 Added 0.08%	787,836 $369 Million
Q1 2023 May 09, 2023	BUY	$310.63 - $364.82 $1.67 Million - $1.96 Million	5,369 Added 0.69%	787,214 $270 Million
Q4 2022 Feb 06, 2023	BUY	$321.55 - $374.67 $244 Million - $284 Million	758,588 Added 3261.76%	781,845 $286 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $624,683 - $711,892	-2,107 Reduced 8.31%	23,257 $7.52 Million

Q2 2022 Aug 04, 2022	SELL	$278.73 - $327.27 $292,666 - $343,633	-1,050 Reduced 3.98%	25,364 $8.22 Million
Q1 2022 May 03, 2022	SELL	$234.69 - $291.66 $261,679 - $325,200	-1,115 Reduced 4.05%	26,414 $7.56 Million
Q4 2021 Feb 07, 2022	BUY	$224.85 - $279.04 $315,689 - $391,772	1,404 Added 5.37%	27,529 $7.6 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $575,716 - $708,500	-2,598 Reduced 9.05%	26,125 $6.04 Million
Q2 2021 Aug 05, 2021	SELL	$180.55 - $233.54 $373,919 - $483,661	-2,071 Reduced 6.73%	28,723 $6.59 Million
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $465,847 - $603,061	-2,835 Reduced 8.43%	30,794 $5.75 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $2,609 - $3,452	20 Added 0.06%	33,629 $5.68 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $95,774 - $110,780	-655 Reduced 1.91%	33,609 $4.98 Million
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $26,192 - $31,522	192 Added 0.56%	34,264 $5.63 Million
Q1 2020 May 11, 2020	SELL	$119.05 - $147.35 $11,905 - $14,735	-100 Reduced 0.29%	34,072 $4.73 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $3.65 Million - $4.53 Million	34,172 New	34,172 $4.49 Million

Others Institutions Holding LLY

# of Institutions

3,725

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Column Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Column Capital Advisors, LLC with notifications on news.

Account

Column Capital Advisors, LLC Eli Lilly & CO Transaction History